Article
Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to…
Infection and Drug Resistance · 2022 · Almangour TA, Ghonem L, Aljabri A, Alruwaili A, Al Musawa M, Damfu N, Almalki MS, Alattas M, Abed H, Naeem D, Almalki N, Alhifany AA
Key facts
| Title | Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study |
|---|---|
| First author | Almangour TA, Ghonem L, Aljabri A, Alruwaili A, Al Musawa M, Damfu N, Almalki MS, Alattas M, Abed H, Naeem D, Almalki N, Alhifany AA |
| Journal | Infection and Drug Resistance |
| Published | Jan 23, 2022 |
| DOI | 10.2147/IDR.S349004 |
| Devices mentioned | DEN070004, DEN130013, K003619, K010418, K020037, K020160, K020162, K020870, K020871, K022045, K031410, K031865 and 224 more |
| Product codes mentioned | JJQ, JSG, JSM, JSP, JST, JTC, JTZ, JWY, LQL, LRG, LTW, LTT and 40 more |
At a glance
- 100–999 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1